ProPhase Labs (PRPH) Common Equity (2010 - 2026)
ProPhase Labs' Common Equity was -$3.11 million in Q2 2026, compared with $11.44 million a year earlier.
Powered by 
Analysis
ProPhase Labs (PRPH) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at ProPhase Labs came in at $3.51 million, down 52.3% from FY2024.
- Common Equity has now declined for three consecutive years, with a five-year compound annual growth rate of -19.8% (FY2020 to FY2025).
- In earlier years, Common Equity was $7.35 million in FY2024 (-85.1%), $49.38 million in FY2023 (-22.4%), $63.63 million in FY2022 (+8.5%) and $58.63 million in FY2021 (+455.4%).
- The Q2 2026 figure marks the lowest quarterly Common Equity in data going back to Q4 2010.
- The best year-over-year quarter for Common Equity over five years was Q4 2021 (growth of 455.4%); the worst was Q4 2024 (a decline of 85.1%).
- Per Business Quant data, PRPH's Common Equity in the three quarters before Q2 2026 was -$435,000 (Q1 2026), $3.51 million (Q4 2025) and $6.86 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 33.88 Bn |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 81.53 Bn |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | -5.94 Bn |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | 41.98 Bn |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 41.95 Bn |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 50.37 Bn |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 11.69 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 11.83 Bn |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 85.49 Bn |
| 10 | ProPhase Labs | 120,537.60 | -425,462.40 | 226,000.00 | -3.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -3.11 Mn |
| Mar 31, 2026 | -435,000.00 |
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 6.86 Mn |
| Jun 30, 2025 | 11.44 Mn |
| Mar 31, 2025 | 15.12 Mn |
| Dec 31, 2024 | 7.35 Mn |
| Sep 30, 2024 | 38.13 Mn |
| Jun 30, 2024 | 44.08 Mn |
| Mar 31, 2024 | 44.87 Mn |
| Dec 31, 2023 | 49.38 Mn |
| Sep 30, 2023 | 56.43 Mn |
| Jun 30, 2023 | 59.26 Mn |
| Mar 31, 2023 | 59.94 Mn |
| Dec 31, 2022 | 63.63 Mn |
| Sep 30, 2022 | 67.92 Mn |
| Jun 30, 2022 | 68.16 Mn |
| Mar 31, 2022 | 66.45 Mn |
| Dec 31, 2021 | 58.63 Mn |
| Sep 30, 2021 | 48.26 Mn |
API Access
ProPhase Labs Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=PRPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "PRPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=PRPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();